Identification of a Vulnerable Group for Post-Acute Sequelae of SARS-CoV-2 (PASC): People with Autoimmune Diseases Recover More Slowly from COVID-19

PURPOSE: Evidence is emerging that a significant percentage of COVID-19 cases experience symptom persistence beyond 30 days and go on to develop post-acute sequelae. Our objective was to compare the risk for COVID-19 symptom persistence by self-reported use of medications for autoimmune disease amon...

Descripción completa

Detalles Bibliográficos
Autores principales: Dreyer, Nancy, Petruski-Ivleva, Natalia, Albert, Lisa, Mohamed, Damir, Brinkley, Emma, Reynolds, Matthew, Toovey, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323859/
https://www.ncbi.nlm.nih.gov/pubmed/34345182
http://dx.doi.org/10.2147/IJGM.S313486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323859/
https://www.ncbi.nlm.nih.gov/pubmed/34345182
http://dx.doi.org/10.2147/IJGM.S313486

Ejemplares similares